Serum immunoglobulins and coproantibody formation in infants after artificial intestinal colonization with Escherichia coli 083 and oral lysozyme administration.
D000284:Administration, Oral; D000906:Antibodies / Q000032:analysis*; D000917:Antibody Formation; D001942:Breast Feeding; D004926:Escherichia coli / Q000276:immunology*; D005243:Feces / Q000032:analysis*; D005260:Female; D006384:Hemagglutination; D006801:Humans; D007109:Immunity; D005779:Immunodiffusion; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D007223:Infant; D007231:Infant, Newborn; D007413:Intestinal Mucosa / Q000276:immunology; D007422:Intestines / Q000382:microbiology*; D008431:Maternal-Fetal Exchange; D009113:Muramidase / Q000008:administration & dosage / Q000494:pharmacology*; D011247:Pregnancy; D013997:Time Factors
D000906:Antibodies; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D009113:Muramidase